WebApr 1, 2010 · Erythromycin (ER), a macrolide antibiotic, was introduced in 1952 and is indicated for the treatment of tonsillitis, acute sinusitis, community-acquired pneumonia, and other infections [1], usually at a dose of 50 mg/kg/day. WebErythromycin is a macrolide antibiotic that acts as a prokinetic agent by acting on motilin receptors and inducing phase III activity of the migratory motor complex (MMC), propagating contents from the stomach to the small intestine. 79 Erythromycin has no effect on esophageal motility, but it has been selectively used in infants with feeding ...
UpToDate
WebErythromycin, at lower doses also reduces gastrointestinal symptoms in these patients . In contrast to the potent prokinetic effect of erythromycin on the stomach, its effect on the … WebJun 18, 2013 · Summary. Only 1 small single-blind, crossover study (n=13) identified in a systematic review (5 studies, varying designs, n = 60) found a statistically significant benefit for erythromycin in the short term for improving symptoms of gastroparesis compared with metoclopramide. The other studies identified in the systematic review did not provide … 0勝1敗
What is the optimal prokinetic dose of erythromycin in …
WebWith intravenous use in children: Dilute reconstituted solution further in glucose 5% (neutralised with Sodium bicarbonate) or sodium chloride 0.9% to a concentration of … WebThe prokinetic effects of erythromycin are reported to be dose dependent. 12,13,51 At antimicrobially ineffective, intravenous low doses (1–3 mg/kg), premature MMCs are induced, whereas at higher (10 mg/kg) doses this effect is lost because of mechanisms that are poorly understood. WebJan 21, 2024 · Prokinetic agents, like erythromycin, were not routinely used in our practice as the beneficial effect of those has been formally proven only in patients with postoperative ileus and in intensive ... 0半次元